Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04339959 · ClinicalTrials.gov registry record
Remote Assessment of Physical Function
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 33
- Enrollment target
NCT04339959: Completed study, sponsored by University of New Mexico.
NCT04339959 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04339959 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the validity and reliability of using videoconferencing to assess physical performance tests self-administered by older cancer survivors in their own homes. This remote assessment will be compared to the traditional face-to-face (i.e., in-person) assessment and to accelerometer data.
Primary Outcome
Comparison of remote assessment to the traditional face-to-face (i.e., in-person; direct observer) assessment. Phase 2 will enroll 10-20 participants, depending on the point at which no new information is learned about the use of the toolkit (including instructions). Comparisons will be made between the direct observer and the remote assessor. The 30-second chair stand test involves standing up from a chair and sitting down as quickly and safely as possible, preferably without the use of upper e
Interventions
- OTHER Remote Assessment of Physical Function with Direct Observation
- OTHER Remote Assessment of Physical Function
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2021-11-13 |
What the finished NCT04339959 record still lists
NCT04339959 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Remote Assessment of Physical Function with Direct Observation is the first listed.
NCT04339959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04339959 about?
NCT04339959 is a clinical study titled "Remote Assessment of Physical Function". The primary objective is to evaluate the validity and reliability of using videoconferencing to assess physical performance tests self-administered by older cancer survivors in their own homes. This remote assessment will be compared to the traditional face-to-face (i.e., in-person) assessment and t...
What is the current status of trial NCT04339959?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2019-11-20. Estimated completion is 2021-11-13.
What interventions are being tested in trial NCT04339959?
The interventions under investigation include: Remote Assessment of Physical Function with Direct Observation (OTHER), Remote Assessment of Physical Function (OTHER).
Who is sponsoring clinical trial NCT04339959?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI